By Liza Heapes
Today’s Washington Post article on congressional conflicts of interest highlights the proposed $4 billion tax on medical-device firms to help offset the cost of health-care reforms. This tax is currently facing opposition from senators including Massachusetts’ own John Kerry, speculated to have significant personal investments in the sector.
Perhaps the Senate should take a hard look at the statute and weigh whether such disclosure would be a benefit or more of a burden.
In Kerry’s defense, his constituency has much more to lose if the medtech sector is to shoulder the cost of healthcare reform more than other industries. There are roughly 225 medtech companies currently based in the Commonwealth, employing about 50,000 in Massachusetts and contributing $7.2 billion or 10 percent of all goods exported.
The latest MS&L TrendSpotter Report looks at the unique circumstances facing Massachusetts medtech companies and how the implications of taxes, incentives and new regulation will affect corporate communications now and into 2010.
The report also includes a comprehensive list of who on Twitter is reporting, advocating and deciding the fates of medtech in Massachusetts and the U.S
To read the full TrendSpotter Report please fill out the form below. We'd love to hear your reactions via the comment section.
Continue reading...





